The FDA has granted clearance to Qiagen’s QIAstat-Dx Gastrointestinal Panel 2 Mini B, expanding the company’s syndromic ...

Inari Medical has launched the Artix thrombectomy system, engineered specifically for certain requirements of the peripheral ...

Buoyed by $110m in funding three months ago, Capstan Medical has reported the first-in-human cases with the mitral technology ...

Vitestro has unveiled Aletta, claimed to be the “world's first” Autonomous Robotic Phlebotomy Device (ARPD), designed for ...

Closing the gap in health interventions between men and women could add $1tn to the global GDP, unlocking seven additional ...

New York City’s Mount Sinai has become the first hospital in the US to perform a deep brain stimulation (DBS) implantation ...

Cadrenal Therapeutics has partnered with Abbott for the TECH-LVAD trial to assess the safety and efficacy of tecarfarin in ...

Cerus Corporation has secured CE mark approval for its INT200, a LED-based illumination device, for the Intercept Blood ...

The US Food and Drug Administration (FDA) has issued an early alert over a ‘potentially high-risk’ issue with certain Baxter ...

C Medical Technologies has closed its Series D financing round. which was led by Boston Scientific, raising gross proceeds of ...

Olympus is set to launch the Retentia HemoClip to assist gastrointestinal (GI) endoscopists in performing haemostasis.

A ‘tumour-on-chip’ model on PDAC has been developed to allow insights into interactions between tumour cells and potential ...